Cibiltech is founded on technical excellence and a deep commitment to patients.
The Paris Transplant Group developed the first universal predictive algorithm for transplantation in 2018 after 20 years of research. Our iBox technology is based on the Paris Transplant Group’s renowned scientific excellence and decades of experience caring for our own transplant patients.
We wanted to help patients worldwide by making our innovative technology available to everyone. With that goal, Alexandre Loupy, Xavier Jouven, and Stephane Tholander founded Cibiltech in 2019.
Together with a team of world-class scientists and business experts, we’re creating a world where science and technology work together in the service of human health.
Cibiltech was founded to take a leap into the future of transplantation
Collaboration with CareDX provides prognostic information on allograft survival on the American Market
The 2019 year ended with the prestigious Paris Innovation Grand Prix being awarded to Cibiltech in E-Health category
Cibiltech was announced among the 2020 winners of EIT Health's bridgehead global program
Launch in France for kidney transplanted patients
Finalist to the Nobel Project's Health Tech Award
Predigraft received CE marking as a class IIa under the MDR for kidney transplanted patients
A new significant milestone for Cibiltech with more than 1000 patients using our app
First patient enrolled in our International Clinical Trial for monitoring kidney Transplant patients using AI
Cibiltech announced as winner of the AI Award funded by the AAC and the NIHR